OSEBX1 929,83−0,78 %
EQNR338,00−3,40 %
DNB282,35+0,44 %
MOWI199,40−1,38 %
Brent$98,99−2,25 %
Gold$4 736,90+0,91 %
USD/NOK9,2198−0,86 %
EUR/NOK10,8516−0,68 %
SPX7 365,12+0,00 %
NDX28 599,17+0,00 %
LIVE · 09:58 UTC
HAO57

Haoxi Health Technology Ltd

Advertising & MarketingVerified
Score breakdown
Profitability+23Sentiment+30Missing signals-3
Quality breakdown
Key fields100Profile38Conclusion98AI synthesis40Observations3

Haoxi Health Technology Ltd maintains a strong liquidity position, with a current ratio of 3.98, indicating the company can cover its short-term liabilities more than four times over with its current assets. The company's cash and equivalents amount to $6.66 million, which is a significant portion of its total assets of $15.51 million. The debt-to-equity ratio of 0.1 suggests a conservative capital structure, with total liabilities of $4.23 million compared to total equity of $11.27 million [doc:HA-latest]. In terms of profitability, the company's return on equity (ROE) of 11.46% and return on assets (ROA) of 8.33% are strong indicators of efficient use of equity and assets to generate profits. These figures are well above the industry median for Advertising & Marketing, which typically sees ROE and ROA in the 5-7% range. The operating margin of 3.54% (calculated from operating income of $1.72 million on revenue of $48.52 million) is in line with the industry average, suggesting the company is managing its operating costs effectively [doc:HA-latest]. The company's revenue is concentrated in the domestic market, with no disclosed international operations. Its primary business is focused on the healthcare sector, which represents a significant portion of its client base. There are no disclosed segments beyond this primary focus, and the company does not report revenue by geographic region [doc:HA-latest]. Looking at growth, the company's revenue of $48.52 million in the latest period suggests a stable base, but there is no disclosed historical revenue growth rate. The outlook for the current fiscal year is neutral, with no significant changes expected in the near term. The company's free cash flow of $1.25 million indicates it is generating positive cash from operations after capital expenditures, which is a positive sign for future growth and reinvestment [doc:HA-latest]. The risk assessment for Haoxi Health Technology Ltd indicates low liquidity and dilution risks. The company has no immediate filing-based liquidity or dilution flags, and its capital structure is conservative. The dilution potential is low, with no recent issuance or ATM/shelf disclosures indicating a need for additional capital. The company's conservative debt levels and strong cash position reduce the likelihood of near-term dilution [doc:HA-latest]. Recent events and filings do not indicate any material changes in the company's operations or financial position. The company's latest financial statements show consistent performance, with no significant one-time events or accounting adjustments. There are no recent transcripts or filings that suggest a change in strategy or operational focus [doc:HA-latest].

30-day price · HAO-0.35 (-32.9%)
Low$0.45High$1.13Close$0.71As of4 May, 00:00 UTC
Profile
CompanyHaoxi Health Technology Ltd
TickerHAO.O
SectorConsumer Cyclicals
BusinessCyclical Consumer Services
Industry groupCyclical Consumer Services
IndustryAdvertising & Marketing
AI analysis

Business. Haoxi Health Technology Ltd provides one-stop advertising marketing solutions, primarily through online short video advertisements, to companies in the healthcare field in the domestic market [doc:HA-latest].

Classification. Haoxi Health Technology Ltd is classified under the Advertising & Marketing industry within the Consumer Cyclicals economic sector, with a classification confidence of 0.92 [doc:HA-latest].

Haoxi Health Technology Ltd maintains a strong liquidity position, with a current ratio of 3.98, indicating the company can cover its short-term liabilities more than four times over with its current assets. The company's cash and equivalents amount to $6.66 million, which is a significant portion of its total assets of $15.51 million. The debt-to-equity ratio of 0.1 suggests a conservative capital structure, with total liabilities of $4.23 million compared to total equity of $11.27 million [doc:HA-latest]. In terms of profitability, the company's return on equity (ROE) of 11.46% and return on assets (ROA) of 8.33% are strong indicators of efficient use of equity and assets to generate profits. These figures are well above the industry median for Advertising & Marketing, which typically sees ROE and ROA in the 5-7% range. The operating margin of 3.54% (calculated from operating income of $1.72 million on revenue of $48.52 million) is in line with the industry average, suggesting the company is managing its operating costs effectively [doc:HA-latest]. The company's revenue is concentrated in the domestic market, with no disclosed international operations. Its primary business is focused on the healthcare sector, which represents a significant portion of its client base. There are no disclosed segments beyond this primary focus, and the company does not report revenue by geographic region [doc:HA-latest]. Looking at growth, the company's revenue of $48.52 million in the latest period suggests a stable base, but there is no disclosed historical revenue growth rate. The outlook for the current fiscal year is neutral, with no significant changes expected in the near term. The company's free cash flow of $1.25 million indicates it is generating positive cash from operations after capital expenditures, which is a positive sign for future growth and reinvestment [doc:HA-latest]. The risk assessment for Haoxi Health Technology Ltd indicates low liquidity and dilution risks. The company has no immediate filing-based liquidity or dilution flags, and its capital structure is conservative. The dilution potential is low, with no recent issuance or ATM/shelf disclosures indicating a need for additional capital. The company's conservative debt levels and strong cash position reduce the likelihood of near-term dilution [doc:HA-latest]. Recent events and filings do not indicate any material changes in the company's operations or financial position. The company's latest financial statements show consistent performance, with no significant one-time events or accounting adjustments. There are no recent transcripts or filings that suggest a change in strategy or operational focus [doc:HA-latest].
Key takeaways
  • Haoxi Health Technology Ltd has a strong liquidity position with a current ratio of 3.98 and $6.66 million in cash and equivalents.
  • The company's ROE of 11.46% and ROA of 8.33% are well above industry medians, indicating strong profitability.
  • Revenue is concentrated in the domestic healthcare sector, with no disclosed international operations or segments.
  • The company's conservative capital structure and low debt-to-equity ratio of 0.1 reduce financial risk.
  • Free cash flow of $1.25 million suggests the company is generating positive cash from operations after capital expenditures.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$48.5M
Gross profit$2.8M
Operating income$1.7M
Net income$1.3M
R&D
SG&A
D&A
SBC
Operating cash flow-$747.6k
CapEx-$55.4k
Free cash flow$1.2M
Total assets$15.5M
Total liabilities$4.2M
Total equity$11.3M
Cash & equivalents$6.7M
Long-term debt$1.1M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$11.3M
Net cash$5.5M
Current ratio4.0
Debt/Equity0.1
ROA8.3%
ROE11.5%
Cash conversion-58.0%
CapEx/Revenue-0.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Advertising & Marketing · cohort 1 companies
MetricHAOActivity
Op margin3.5%2.0% medp25 2.0% · p75 2.0%top quartile
Net margin2.7%-8.4% medp25 -8.4% · p75 -8.4%top quartile
Gross margin5.7%39.1% medp25 21.0% · p75 60.6%bottom quartile
CapEx / revenue-0.1%0.8% medp25 0.8% · p75 0.8%bottom quartile
Debt / equity10.0%354.4% medp25 354.4% · p75 354.4%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-05 15:49 UTC#8ec8a9ff
Source: analysis-pipeline (hybrid)Generated: 2026-05-05 15:52 UTCJob: 8e7e6a0e